4//SEC Filing
Zinda Michael 4
Accession 0001209191-23-006064
CIK 0001808158other
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 9:46 PM ET
Size
7.5 KB
Accession
0001209191-23-006064
Insider Transaction Report
Form 4
Zinda Michael
EVP, CHIEF SCIENTIFIC OFFICER
Transactions
- Award
Common Shares
2023-01-30+24,550→ 70,591 total - Award
Employee Stock Option (right to buy)
2023-01-30+97,100→ 97,100 totalExercise: $12.42Exp: 2033-01-29→ Common Shares (97,100 underlying)
Footnotes (2)
- [F1]Represents a restricted stock unit ("RSU") award. Thirty-three and one third percent (33 1/3%) of the RSUs shall vest on each of January 30, 2024, January 30, 2025 and January 30, 2026, subject to Reporting Person continuing to provide service through each such date.
- [F2]Twenty-five percent (25%) of the shares subject to the option shall vest on January 30, 2024, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.
Documents
Issuer
Repare Therapeutics Inc.
CIK 0001808158
Entity typeother
Related Parties
1- filerCIK 0001815366
Filing Metadata
- Form type
- 4
- Filed
- Jan 31, 7:00 PM ET
- Accepted
- Feb 1, 9:46 PM ET
- Size
- 7.5 KB